Jose A. Fernandez-Albarral

Mr. Jose A. Fernandez-Albarral

Facultad de Medicina, Universidad Complutense de Madrid
+1
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2020 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
PRPilar Rojas
Pilar Rojas
ARAna I. Ramírez
Ana I. Ramírez
JFJose A. Fernandez-Albarral
Jose A. Fernandez-Albarral
Inés López-CuencaInés López-Cuenca
Inés López-Cuenca
Elena Salobrar-GarciaElena Salobrar-Garcia
Elena Salobrar-Garcia
José M RamírezJosé M Ramírez
José M Ramírez
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that causes degeneration of the lower and upper motor neurons and is the most prevalent motor neuron disease. This disease is characterized by muscle weakness, stiffness, and hyperreflexia. Patients survive for a short period from the onset of the disease. Most cases are sporadic, with only 10% of the cases being genetic. Many genes are now known to be involved in familial ALS cases, including some of the sporadic cases. It has also been observed that, in addition to genetic factors, there are numerous molecular mechanisms involved in these pathologies, such as excitotoxicity, mitochondrial disorders, alterations in axonal transport, oxidative stress, accumulation of misfolded proteins, and neuroinflammation. This pathology affects the motor neurons, the spinal cord, the cerebellum, and the brain, but recently, it has been shown that it also affects the visual system. This impact occurs not only at the level of the oculomotor system but also at the retinal level, which is why the retina is being proposed as a possible biomarker of this pathology. The current review discusses the main aspects mentioned above related to ALS, such as the main genes involved, the most important molecular mechanisms that affect this pathology, its ocular involvement, and the possible usefulness of the retina as a biomarker.

28 January 2020 in Neural Regeneration Research
Verified
Journal Article
Open access
PDF file
JFJose A. Fernandez-Albarral
Jose A. Fernandez-Albarral
RHRosa de Hoz
Rosa de Hoz
ARAna I. Ramírez
Ana I. Ramírez
Inés López-CuencaInés López-Cuenca
Inés López-Cuenca
Elena Salobrar-GarciaElena Salobrar-Garcia
Elena Salobrar-Garcia
JUAN J. SALAZARJUAN J. SALAZAR
JUAN J. SALAZAR
Saffron ( Crocus sativus L.) has been traditionally used in food preparation and as a medicinal plant. It currently has numerous therapeutic properties attributed to it, such as protection against ischemia, as well as anticonvulsant, antidepressant, anxiolytic, hypolipidemic, anti-atherogenic, anti-hypertensive, antidiabetic, and anti-cancer properties. In addition, saffron has remarkable beneficial properties, such as anti-apoptotic, anti-inflammatory and antioxidant activities, due to its main metabolites, among which crocin and crocetin stand out. Furthermore, increasing evidence underwrites the possible neuroprotective role of the main bioactive saffron constituents in neurodegenerative diseases, such as Parkinson’s and Alzheimer’s diseases, both in experimental models and in clinical studies in patients. Currently, saffron supplementation is being tested for ocular neurodegenerative pathologies, such as diabetic retinopathy, retinitis pigmentosa, age-related macular degeneration and glaucoma, among others, and shows beneficial effects. The present article provides a comprehensive and up to date report of the investigations on the beneficial effects of saffron extracts on the main neurodegenerative ocular pathologies and other ocular diseases. This review showed that saffron extracts could be considered promising therapeutic agents to help in the treatment of ocular neurodegenerative diseases.

Verified
Journal Article
Open access
PDF file
JFJose A. Fernandez-Albarral
Jose A. Fernandez-Albarral
Ana I. RamírezAna I. Ramírez
Ana I. Ramírez
RHRosa de Hoz
Rosa de Hoz
NLNerea López-Villarín
Nerea López-Villarín
Elena Salobrar-GarciaElena Salobrar-Garcia
Elena Salobrar-Garcia
JUAN J. SALAZARJUAN J. SALAZAR
JUAN J. SALAZAR
Glaucoma is a neurodegenerative disease characterized by the loss of retinal ganglion cells (RGCs). An increase in the intraocular pressure is the principal risk factor for such loss, but controlling this pressure does not always prevent glaucomatous damage. Activation of immune cells resident in the retina (microglia) may contribute to RGC death. Thus, a substance with anti-inflammatory activity may protect against RGC degeneration. This study investigated the neuroprotective and anti-inflammatory effects of a hydrophilic saffron extract standardized to 3% crocin content in a mouse model of unilateral, laser-induced ocular hypertension (OHT). Treatment with saffron extract decreased microglion numbers and morphological signs of their activation, including soma size and process retraction, both in OHT and in contralateral eyes. Saffron extract treatment also partially reversed OHT-induced down-regulation of P2RY12. In addition, the extract prevented retinal ganglion cell death in OHT eyes. Oral administration of saffron extract was able to decrease the neuroinflammation associated with increased intraocular pressure, preventing retinal ganglion cell death. Our findings indicate that saffron extract may exert a protective effect in glaucomatous pathology.

17 March 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Ana I. RamírezAna I. Ramírez
Ana I. Ramírez
RHRosa de Hoz
Rosa de Hoz
JFJose A. Fernandez-Albarral
Jose A. Fernandez-Albarral
Elena Salobrar-GarciaElena Salobrar-Garcia
Elena Salobrar-Garcia
BRBlanca Rojas
Blanca Rojas
JUAN J. SALAZARJUAN J. SALAZAR
JUAN J. SALAZAR
Microglial activation is associated with glaucoma. In the model of unilateral laser-induced ocular hypertension (OHT), the time point at which the inflammatory process peaks remains unknown. Different time points (1, 3, 5, 8, and 15 d) were compared to analyze signs of microglial activation both in OHT and contralateral eyes. In both eyes, microglial activation was detected in all retinal layers at all time points analyzed, including: i) increase in the cell number in the outer segment photoreceptor layer and plexiform layers (only in OHT eyes) from 3 d onward; ii) increase in soma size from 1 d onward; iii) retraction of the processes from 1 d in OHT eyes and 3 d in contralateral eyes; iv) increase in the area of the retina occupied by Iba-1+ cells in the nerve fiber layer/ganglion cell layer from 1 d onward; v) increase in the number of vertical processes from 1 d in contralateral eyes and 3 d in OHT eyes. In OHT eyes at 24 h and 15 d, most Iba-1+ cells were P2RY12+ and were down-regulated at 3 and 5 d. In both eyes, microglial activation was stronger at 3 and 5 d (inflammation peaked in this model). These time points could be useful to identify factors implicated in the inflammatory process.

28 May 2021 in Foods
Verified
Journal Article
Open access
PDF file
MVMar Valero-Velló
Mar Valero-Velló
Cristina Peris-MartínezCristina Peris-Martínez
Cristina Peris-Martínez
Jose Javier Garcia-MedinaJose Javier Garcia-Medina
Jose Javier Garcia-Medina
SGSilvia María Sanz González
Silvia María Sanz González
Ana I. RamírezAna I. Ramírez
Ana I. Ramírez
MPMaria Dolores Pinazo-Duran
Maria Dolores Pinazo-Duran
Adherence to a healthy diet offers a valuable intervention to compete against the increasing cases of ocular diseases worldwide, such as dry eye disorders, myopia progression, cataracts, glaucoma, diabetic retinopathy, or age macular degeneration. Certain amounts of micronutrients must be daily provided for proper functioning of the visual system, such as vitamins, carotenoids, trace metals and omega-3 fatty acids. Among natural foods, the following have to be considered for boosting eye/vision health: fish, meat, eggs, nuts, legumes, citrus fruits, nuts, leafy green vegetables, orange-colored fruits/vegetables, olives-olive oil, and dairy products. Nutritional supplements have received much attention as potential tools for managing chronic-degenerative ocular diseases. A systematic search of PubMed, Web of Science, hand-searched publications and historical archives were performed by the professionals involved in this study, to include peer-reviewed articles in which natural food, nutrient content, and its potential relationship with ocular health. Five ophthalmologists and two researchers collected the characteristics, quality and suitability of the above studies. Finally, 177 publications from 1983 to 2021 were enclosed, mainly related to natural food, Mediterranean diet (MedDiet) and nutraceutic supplementation. For the first time, original studies with broccoli and tigernut (chufa de Valencia) regarding the ocular surface dysfunction, macular degeneration, diabetic retinopathy and glaucoma were enclosed. These can add value to the diet, counteract nutritional defects, and help in the early stages, as well as in the course of ophthalmic pathologies. The main purpose of this review, enclosed in the Special Issue “Health Benefits and Nutritional Quality of Fruits, Nuts and Vegetables,” is to identify directions for further research on the role of diet and nutrition in the eyes and vision, and the potential antioxidant, anti-inflammatory and neuroprotective effects of natural food (broccoli, saffron, tigernuts and walnuts), the Mediterranean Diet, and nutraceutic supplements that may supply a promising and highly affordable scenario for patients at risk of vision loss. This review work was designed and carried out by a multidisciplinary group involved in ophthalmology and ophthalmic research and especially in nutritional ophthalmology.

15 November 2020 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
Elena Salobrar-GarciaElena Salobrar-Garcia
Elena Salobrar-Garcia
CHCarmen Mendez Hernandez
Carmen Mendez Hernandez
Rosa de Hoz MontañanaRosa de Hoz Montañana
Rosa de Hoz Montañana
Ana I. RamírezAna I. Ramírez
Ana I. Ramírez
Inés López-CuencaInés López-Cuenca
Inés López-Cuenca
José M RamírezJosé M Ramírez
José M Ramírez
In Alzheimer’s disease (AD), vascular changes could be caused by amyloid beta (Aβ) aggregates replacing the contractile smooth musculature of the arteriole walls. These changes happen in the brain vascular network, but also in the eye, and are related to decreased vascular density and low blood flow. In patients with Alzheimer’s disease, thinning of the choroid and the retina has been shown. The aim of this prospective study was to assess the retinal and choroidal vascular systems, analyzing the choroidal thickness with optical coherence tomography (OCT), the foveal avascular zone (FAZ) with OCT-angiography (OCTA), and the optic nerve head (ONH) hemoglobin with the Laguna ONhE program, to evaluate which of the two ocular vascular systems shows earlier changes in mild AD patients. These patients, compared to controls, showed a significantly thinner choroid at all the analyzed points, with the exception of the temporal macula (at 1000 and 1500 µm from the fovea). On the other hand, the FAZ and ONH hemoglobin did not show significant differences. In conclusion, a thinner choroid was the main ocular vascular change observed in mild AD patients, while the retinal vessels were not yet affected. Therefore, choroidal thickness could be used an early biomarker in AD.